ClinicalTrials.gov
public full text
Public Domain
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
This phase 1 study will investigate the safety, dosing, and initial antitumor activity of JZP815 in participants with advanced or metastatic solid tumors harboring alterations in the MAPK pathway.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors#966715
- A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors#1140308
- Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors#898373
- A Phase I Study of LJM716 in Japanese Patients With Advanced Solid Tumors#1162274
- a Single-arm, Single-center, Open Clinical Study#916801
Record · ID 979747
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive